These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(40):816-9. PubMed ID: 23051612 [TBL] [Abstract][Full Text] [Related]
12. The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults. Frenck RW; Yeh S Expert Opin Biol Ther; 2012 Jan; 12(1):63-77. PubMed ID: 22074323 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants. Gattringer R; Winkler H; Roedler S; Jaksch P; Herkner H; Burgmann H Transpl Infect Dis; 2011 Oct; 13(5):540-4. PubMed ID: 21489090 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the United States during an influenza pandemic. Dhankhar P; Grabenstein JD; O'Brien MA; Dasbach EJ Clin Ther; 2010 Aug; 32(8):1501-16. PubMed ID: 20728763 [TBL] [Abstract][Full Text] [Related]
15. [23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010]. Ripoll M E; Valenzuela B MT; Vergara F R; Abarca V K; Muñoz M A; Jiménez de la Jara J; Pinto C ME; Luchsinger F V Rev Chilena Infectol; 2010 Apr; 27(2):133-7. PubMed ID: 20556313 [TBL] [Abstract][Full Text] [Related]
16. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
17. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants. Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934 [TBL] [Abstract][Full Text] [Related]
19. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Zangeneh TT; Baracco G; Al-Tawfiq JA Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802 [TBL] [Abstract][Full Text] [Related]
20. Prevnar(tm): a pneumococcal conjugate vaccine for infants and young children. Brown A Issues Emerg Health Technol; 2001 Feb; (14):1-6. PubMed ID: 11902222 [No Abstract] [Full Text] [Related] [Next] [New Search]